Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer ...

A new generation of CAR T cell therapy is bringing hope in the fight against cancer, targeting not only blood cancers but ...

Experts say bureaucracy is "stifling innovation" and that applying for funding to pay for new treatments can be "cumbersome".

Elahere, validated in a phase 3 trial, is FDA-approved and offers the first major advancement for platinum-resistant ovarian ...

Recent advances in cancer treatment highlight the potential of natural medicines to target the tumor vascular microenvironment, offering a novel strategy to inhibit tumor growth and metastasis.

Over the last several decades, there have been significant leaps and bounds in the research and treatment of cancer.

“What we found is that there is a 79 per cent percent reduction in the harms of the prostate cancer diagnostic process – ...

UCSF researchers studied personalized chemotherapy conditioning for children to maximize chemotherapy exposure for each child ...

Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) has shared an announcement. Nanjing Leads Biolabs Co., Ltd. has announced the successful dosing of the first patient in a Phase Ib/II clinical ...

An update from TransThera Sciences (Nanjing). Inc. ( (HK:2617) ) is now available.

CINCINNATI (WKRC) — As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized treatment in extending lives beyond a cancer diagnosis.

Ovarian cancer management is challenging due to high morbidity and mortality, often from late-stage diagnoses. Advances in tumor genomics have led to targeted therapies, improving outcomes for ...